Samira Navardi
2PUBLICATIONS
3CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Sep 15, 2023
Comparing infusion-related reactions of the first full dose (600 mg) biosimilar ocrelizumab administration with the standard divided protocol in multiple sclerosis patients: a randomized controlled trial study.Naghmeh Abbasi Kasbi, F Ghadiri, M A Sahraian
|Dec 19, 2022
The barriers and facilitators to health-promoting lifestyle behaviors among people with multiple sclerosis during the coronavirus disease 2019 pandemic: a content analysis study.Soheileddin Salmani, Seyyed Hossein Mousavi, Samira Navardi
Pageof 1

